Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China
· Delayed Price · Currency is CNY 7.27
-0.11 (-1.49%)
Apr 29, 2026, 3:04 PM CST
SHE:000952 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 638.58 | 623.97 | 635.05 | 730.11 | 794.85 | 785.1 | Upgrade
|
| Other Revenue | - | - | 3.75 | 7.71 | 2.79 | 0.47 | Upgrade
|
| Revenue | 638.58 | 623.97 | 638.8 | 737.82 | 797.64 | 785.57 | Upgrade
|
| Revenue Growth (YoY) | 5.18% | -2.32% | -13.42% | -7.50% | 1.54% | 14.15% | Upgrade
|
| Cost of Revenue | 479.17 | 458.17 | 524.77 | 549.89 | 510.22 | 487.42 | Upgrade
|
| Gross Profit | 159.41 | 165.8 | 114.03 | 187.93 | 287.42 | 298.15 | Upgrade
|
| Selling, General & Admin | 217.47 | 228.16 | 263.03 | 194.83 | 149.94 | 137.29 | Upgrade
|
| Research & Development | 36.7 | 41.91 | 56.82 | 74.75 | 68.98 | 52.06 | Upgrade
|
| Other Operating Expenses | 8.73 | 7.81 | 14.03 | 12.92 | 13.5 | 15.97 | Upgrade
|
| Operating Expenses | 262.9 | 277.88 | 331.08 | 282.64 | 236.3 | 210.87 | Upgrade
|
| Operating Income | -103.49 | -112.08 | -217.04 | -94.7 | 51.13 | 87.28 | Upgrade
|
| Interest Expense | - | - | -61.98 | -49.15 | -21.1 | -16.71 | Upgrade
|
| Interest & Investment Income | 18.38 | 18.38 | 2.06 | 3.46 | 8.31 | 21.95 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 4.31 | 2.07 | 4.33 | -2.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -62.65 | -59.84 | -0.38 | -0.04 | -1.01 | 7.3 | Upgrade
|
| EBT Excluding Unusual Items | -148.12 | -153.54 | -273.03 | -138.36 | 41.65 | 97.72 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -27.92 | -10.02 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.55 | 0.55 | -2.4 | 0.25 | -4.31 | 0.54 | Upgrade
|
| Asset Writedown | -289.7 | -290.12 | -30.68 | -0.12 | -0.14 | -0.01 | Upgrade
|
| Legal Settlements | - | - | 1.04 | 0.9 | -0.75 | 5.55 | Upgrade
|
| Other Unusual Items | - | - | 12.71 | 6.69 | 23.63 | 20.54 | Upgrade
|
| Pretax Income | -437.27 | -443.1 | -320.29 | -140.67 | 60.08 | 124.34 | Upgrade
|
| Income Tax Expense | -4.69 | -4.16 | -5.16 | 11.75 | 12.4 | 18.53 | Upgrade
|
| Earnings From Continuing Operations | -432.57 | -438.95 | -315.13 | -152.41 | 47.68 | 105.81 | Upgrade
|
| Minority Interest in Earnings | 32.7 | 34.45 | 19.84 | 12.17 | 2.65 | 4.3 | Upgrade
|
| Net Income | -399.87 | -404.49 | -295.29 | -140.25 | 50.33 | 110.11 | Upgrade
|
| Net Income to Common | -399.87 | -404.49 | -295.29 | -140.25 | 50.33 | 110.11 | Upgrade
|
| Net Income Growth | - | - | - | - | -54.29% | 47.50% | Upgrade
|
| Shares Outstanding (Basic) | 348 | 348 | 352 | 354 | 351 | 344 | Upgrade
|
| Shares Outstanding (Diluted) | 348 | 353 | 352 | 354 | 353 | 344 | Upgrade
|
| Shares Change (YoY) | -0.94% | 0.21% | -0.60% | 0.36% | 2.54% | 2.85% | Upgrade
|
| EPS (Basic) | -1.15 | -1.16 | -0.84 | -0.40 | 0.14 | 0.32 | Upgrade
|
| EPS (Diluted) | -1.15 | -1.16 | -0.84 | -0.40 | 0.14 | 0.32 | Upgrade
|
| EPS Growth | - | - | - | - | -55.42% | 43.41% | Upgrade
|
| Free Cash Flow | 62.98 | 24.79 | -154.28 | -715.1 | -158.63 | -20.7 | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.07 | -0.44 | -2.02 | -0.45 | -0.06 | Upgrade
|
| Dividend Per Share | - | - | - | - | - | 0.060 | Upgrade
|
| Gross Margin | 24.96% | 26.57% | 17.85% | 25.47% | 36.03% | 37.95% | Upgrade
|
| Operating Margin | -16.21% | -17.96% | -33.98% | -12.83% | 6.41% | 11.11% | Upgrade
|
| Profit Margin | -62.62% | -64.83% | -46.23% | -19.01% | 6.31% | 14.02% | Upgrade
|
| Free Cash Flow Margin | 9.86% | 3.97% | -24.15% | -96.92% | -19.89% | -2.63% | Upgrade
|
| EBITDA | 55.03 | 47.57 | -52.84 | 24.04 | 148.58 | 178.15 | Upgrade
|
| EBITDA Margin | 8.62% | 7.62% | -8.27% | 3.26% | 18.63% | 22.68% | Upgrade
|
| D&A For EBITDA | 158.52 | 159.65 | 164.2 | 118.75 | 97.45 | 90.87 | Upgrade
|
| EBIT | -103.49 | -112.08 | -217.04 | -94.7 | 51.13 | 87.28 | Upgrade
|
| EBIT Margin | -16.21% | -17.96% | -33.98% | -12.83% | 6.41% | 11.11% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 20.64% | 14.90% | Upgrade
|
| Revenue as Reported | - | - | 638.8 | 737.82 | 797.64 | 785.57 | Upgrade
|
| Advertising Expenses | - | - | 15.88 | 9.05 | 5.84 | 6.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.